Series B · Biotech · Stockholm, Sweden · Founded 2014 · 50–60 employees
EnginZyme is a Swedish biotechnology company that develops cell-free biomanufacturing technology to replace traditional fossil-based chemical production with sustainable enzyme-based processes. The company's proprietary platform immobilizes enzymes onto specially designed porous materials called EziG, creating reusable biocatalysts for multi-step enzymatic reactions. Founded in 2014 as a spinout from Stockholm University, EnginZyme has raised €21 million in Series B funding in 2022 and is recognized as a Technology Pioneer by the World Economic Forum. The company targets applications in cosmetics, food, pharmaceuticals, and eventually commodity chemicals like bioplastics.